Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | EED | O75530 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 2/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.34 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.33 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29960656 | 0.98 | DRD2 (0.42) | DRD2DRD3EEDHTR2BKDM1A | |
| SCHEMBL10717880 | 0.91 | DRD2 (0.44) | DRD2DRD3HTR2BSSTR4LTB4R | |
| SCHEMBL10717883 | 0.91 | DRD2 (0.44) | DRD2DRD3HTR2BSSTR4LTB4R | |
| SCHEMBL30849006 | 0.88 | DRD2 (0.43) | DRD2DRD3EEDHTR2BKDM1A | |
| SCHEMBL29960480 | 0.82 | DRD2 (0.48) | DRD2DRD3HTR2BSSTR4LTB4R | |
| SCHEMBL7846708 | 0.82 | DRD2 (0.48) | DRD2DRD3HTR2BSSTR4LTB4R | |
| SCHEMBL7846711 | 0.82 | DRD2 (0.48) | DRD2DRD3HTR2BSSTR4LTB4R | |
| SCHEMBL7847793 | 0.82 | DRD2 (0.48) | DRD2DRD3HTR2BSSTR4LTB4R | |
| SCHEMBL6245152 | 0.82 | DRD2 (0.48) | DRD2DRD3HTR2BSSTR4LTB4R | |
| SCHEMBL8528971 | 0.81 | DRD2 (0.44) | DRD2DRD3HTR2BSSTR4LTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022204150-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |